Vivos Therapeutics, Inc. SEC filings VVOS
Vivos Therapeutics, Inc. has 301 filings in SEC EDGAR's recent list, going back to Sep 28, 2017. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | May 8, 2026 | — |
| S-3/A | Filing | Apr 30, 2026 | — |
| S-3 | Shelf registration | Feb 17, 2026 | — |
| 424B3 | Prospectus | Jan 14, 2026 | — |
| POS AM | Filing | Jan 2, 2026 | — |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 424B5 | Prospectus supplement | Sep 12, 2025 | — |
| S-3/A | Filing | Sep 5, 2025 | — |
| 424B5 | Prospectus supplement | Feb 14, 2025 | — |
| S-3 | Shelf registration | Feb 11, 2025 | — |
| 424B1 | Filing | Jan 31, 2025 | — |
| S-1/A | Amended registration statement | Jan 29, 2025 | — |
| S-1 | Registration statement | Jan 22, 2025 | — |
| 424B5 | Prospectus supplement | Dec 26, 2024 | — |
| 424B5 | Prospectus supplement | Sep 20, 2024 | — |
| 424B1 | Filing | Aug 8, 2024 | — |
| S-3 | Shelf registration | Jul 30, 2024 | — |
| 424B1 | Filing | Apr 26, 2024 | — |
| S-1/A | Amended registration statement | Apr 22, 2024 | — |
| S-1 | Registration statement | Apr 9, 2024 | — |
| 424B1 | Filing | Dec 1, 2023 | — |
| S-1/A | Amended registration statement | Nov 30, 2023 | — |
| S-1 | Registration statement | Nov 22, 2023 | — |
| 424B3 | Prospectus | Nov 3, 2023 | — |
| 424B1 | Filing | Feb 10, 2023 | — |
| S-1 | Registration statement | Jan 30, 2023 | — |
| S-3 | Shelf registration | Feb 7, 2022 | — |
| S-8 | Employee stock plan registration | Jun 11, 2021 | — |
| 424B4 | Prospectus | May 19, 2021 | — |
| S-1/A | Amended registration statement | May 18, 2021 | — |
| 424B4 | Prospectus | May 10, 2021 | — |
| S-1MEF | Filing | May 6, 2021 | — |
| S-1 | Registration statement | May 3, 2021 | — |
| S-1 | Registration statement | Apr 27, 2021 | — |
| 424B4 | Prospectus | Dec 14, 2020 | — |
| S-1MEF | Filing | Dec 10, 2020 | — |
| S-1/A | Amended registration statement | Nov 27, 2020 | — |
| S-1/A | Amended registration statement | Nov 19, 2020 | — |
| S-1/A | Amended registration statement | Oct 26, 2020 | — |
| S-1 | Registration statement | Oct 9, 2020 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- VVOS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Littleton, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1716166
- Former names
- Vivos BioTechnologies, Inc. (until Sep 29, 2017)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.